What does CUSIP 427746102 represent in this 13F holders report?

CUSIP 427746102 is the security identifier for HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock used to aggregate holder disclosures.

How many institutions held HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock in Q2 2019?

170 institutional investors reported HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock for Q2 2019. Use the holders table for investor-level position and value details.

- Common Stock (HRTX)

CUSIP: 427746102

Q2 2019 13F Holders as of 30 Jun 2019

Type / Class: Equity / Common Stock
Shares outstanding: 182,615,507
Total 13F shares: 93,875,302
Share change: +2,076,972
Total reported value: $1,744,712,239
Put/Call ratio: 93%
Price per share: $18.59
Number of holders: 170
Value change: +$2,233,456
Number of buys: 96
Number of sells: 88

Quarterly Holders Quick Answers

What is CUSIP 427746102?
CUSIP 427746102 identifies HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2019
Previous quarter: Q1 2019

Recent filing periods for CUSIP 427746102:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of HRTX - HERON THERAPEUTICS, INC. /DE/ - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FRANKLIN RESOURCES INC	13F	Company	4.7%	8,578,877	$209,635,000	—	31 Mar 2019	13F
FMR LLC	13F	Company	4.6%	8,473,847	$207,101,000	—	31 Mar 2019	13F
VANGUARD GROUP INC	13F	Company	3.5%	6,414,507	$156,770,000	—	31 Mar 2019	13F
TANG CAPITAL MANAGEMENT LLC	13F	Company	3.1%	5,744,096	$140,386,000	—	31 Mar 2019	13F
JANUS HENDERSON GROUP PLC	13F	Company	2.8%	5,197,675	$127,031,000	—	31 Mar 2019	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	2.8%	5,144,988	$125,744,000	—	31 Mar 2019	13F
BAKER BROS. ADVISORS LP	13F	Company	2.7%	5,018,104	$122,642,000	—	31 Mar 2019	13F
BlackRock Finance, Inc.	13F	Company	2.7%	4,858,735	$118,747,000	—	31 Mar 2019	13F
STATE STREET CORP	13F	Company	1.8%	3,232,627	$79,005,000	—	31 Mar 2019	13F
ArrowMark Colorado Holdings LLC	13F	Company	1.5%	2,668,643	$65,222,000	—	31 Mar 2019	13F
Clearbridge Investments, LLC	13F	Company	1.2%	2,180,577	$53,293,000	—	31 Mar 2019	13F
BRIDGER MANAGEMENT, LLC	13F	Company	1.1%	2,036,199	$49,765,000	—	31 Mar 2019	13F
FIL Ltd	13F	Company	0.98%	1,786,308	$43,658,000	—	31 Mar 2019	13F
EAGLE ASSET MANAGEMENT INC	13F	Company	0.92%	1,683,924	$41,155,000	—	31 Mar 2019	13F
Rubric Capital Management LP	13F	Company	0.82%	1,500,000	$36,660,000	—	31 Mar 2019	13F
D. E. Shaw & Co., Inc.	13F	Company	0.81%	1,471,596	$35,966,000	—	31 Mar 2019	13F
CARILLON TOWER ADVISERS, INC.	13F	Company	0.7%	1,274,695	$31,153,000	—	31 Mar 2019	13F
Allianz Asset Management GmbH	13F	Company	0.61%	1,117,985	$27,324,000	—	31 Mar 2019	13F
First Light Asset Management, LLC	13F	Company	0.61%	1,112,966	$27,201,000	—	31 Mar 2019	13F
KINGDON CAPITAL MANAGEMENT, L.L.C.	13F	Company	0.6%	1,088,166	$26,595,000	—	31 Mar 2019	13F
ORBIMED ADVISORS LLC	13F	Company	0.59%	1,069,000	$26,126,000	—	31 Mar 2019	13F
HIGHLAND CAPITAL MANAGEMENT LP	13F	Company	0.57%	1,045,392	$25,550,000	—	31 Mar 2019	13F
CITADEL ADVISORS LLC	13F	Company	0.52%	949,624	$23,209,000	—	31 Mar 2019	13F
JPMORGAN CHASE & CO	13F	Company	0.49%	889,696	$21,744,000	—	31 Mar 2019	13F
NORTHERN TRUST CORP	13F	Company	0.46%	841,072	$20,556,000	—	31 Mar 2019	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.45%	815,228	$19,924,000	—	31 Mar 2019	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.43%	791,071	$19,333,000	—	31 Mar 2019	13F
NORGES BANK	13F	Company	0.35%	647,140	$15,816,000	—	31 Mar 2019	13F
STELLIAM INVESTMENT MANAGEMENT, LP	13F	Company	0.35%	640,000	$15,642,000	—	31 Mar 2019	13F
Kavi Asset Management, LP	13F	Company	0.33%	609,615	$14,899,000	—	31 Mar 2019	13F
S.c.a. Candriam	13F	Individual	0.32%	588,600	$14,386,000	—	31 Mar 2019	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.31%	566,656	$13,849,000	—	31 Mar 2019	13F
OppenheimerFunds, Inc.	13F	Company	0.28%	515,908	$12,608,000	—	31 Mar 2019	13F
Carlson Capital, L.P.	13F	Company	0.27%	500,096	$12,222,000	—	31 Mar 2019	13F
WS MANAGEMENT LLLP	13F	Company	0.25%	457,203	$11,174,000	—	31 Mar 2019	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.25%	449,134	$10,977,000	—	31 Mar 2019	13F
University Of Notre Dame du Lac	13F	Individual	0.23%	412,705	$10,087,000	—	31 Mar 2019	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.22%	396,219	$9,684,000	—	31 Mar 2019	13F
NEXTHERA CAPITAL LP	13F	Company	0.21%	388,623	$9,498,000	—	31 Mar 2019	13F
PALISADE CAPITAL MANAGEMENT, LP	13F	Company	0.21%	384,741	$9,403,000	—	31 Mar 2019	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.21%	380,406	$9,297,000	—	31 Mar 2019	13F
DEUTSCHE BANK AG\	13F	Company	0.2%	358,670	$8,763,000	—	31 Mar 2019	13F
Rock Springs Capital Management LP	13F	Company	0.19%	350,000	$8,554,000	—	31 Mar 2019	13F
Bank of New York Mellon Corp	13F	Company	0.16%	297,740	$7,277,000	—	31 Mar 2019	13F
Invesco Ltd.	13F	Company	0.16%	288,671	$7,054,000	—	31 Mar 2019	13F
Pier Capital, LLC	13F	Company	0.15%	269,514	$6,587,000	—	31 Mar 2019	13F
TEACHERS ADVISORS, LLC	13F	Company	0.14%	264,496	$6,464,000	—	31 Mar 2019	13F
C WorldWide Group Holding A/S	13F	Company	0.14%	252,069	$6,161,000	—	31 Mar 2019	13F
Sofinnova Investments, Inc.	13F	Company	0.13%	233,651	$5,710,000	—	31 Mar 2019	13F
Broadfin Capital, LLC	13F	Company	0.11%	207,998	$5,083,000	—	31 Mar 2019	13F

Institutional Holders of HERON THERAPEUTICS, INC. /DE/ - Common Stock (HRTX) as of Q2 2019

As of 30 Jun 2019, HERON THERAPEUTICS, INC. /DE/ - Common Stock (HRTX) was held by 170 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 93,875,302 shares. The largest 10 holders included FRANKLIN RESOURCES INC, FMR LLC, VANGUARD GROUP INC, BAKER BROS. ADVISORS LP, TANG CAPITAL MANAGEMENT LLC, JANUS HENDERSON GROUP PLC, BlackRock Inc., WELLINGTON MANAGEMENT GROUP LLP, STATE STREET CORP, and ArrowMark Colorado Holdings LLC. This page lists 170 institutional shareholders reporting positions in this security for the Q2 2019 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2019 vs Q1 2019 Across Filers

Q1 2019 holders

189

Q2 2019 holders

170

Holder diff

-19

Investor	Q1 2019 Shares	Q2 2019 Shares	Share Diff	Share Chg %	Q1 2019 Value $	Q2 2019 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.